Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,060 JPY | -1.38% | -5.65% | +13.44% |
Mar. 04 | Jefferies Adjusts Chugai’s Price Target to 7,000 Yen From 6,200 Yen, Keeps at Buy | MT |
Feb. 26 | Interest Rates, Central Bank Outlooks Churn Asian Stock Markets | MT |
Sales 2023 | 1,111B 7.39B | Sales 2024 * | 1,092B 7.26B | Capitalization | 10,110B 67.22B |
---|---|---|---|---|---|
Net income 2023 | 325B 2.16B | Net income 2024 * | 344B 2.29B | EV / Sales 2023 | 7.24 x |
Net cash position 2023 | 739B 4.91B | Net cash position 2024 * | 802B 5.33B | EV / Sales 2024 * | 8.52 x |
P/E ratio 2023 |
27
x | P/E ratio 2024 * |
29.4
x | Employees | 7,771 |
Yield 2023 |
1.5% | Yield 2024 * |
1.38% | Free-Float | 38.08% |
Latest transcript on Chugai Pharmaceutical Co., Ltd
1 day | -1.38% | ||
1 week | -5.65% | ||
Current month | +1.00% | ||
1 month | +4.86% | ||
3 months | +13.63% | ||
6 months | +35.94% | ||
Current year | +13.44% |
Managers | Title | Age | Since |
---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 60 | 87-03-31 |
Itagaki Toshiaki
DFI | Director of Finance/CFO | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.57% | 14 M€ | +11.51% | ||
1.87% | 58 M€ | +17.09% | ||
1.53% | 65,729 M€ | +19.62% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 6,060 | -1.38% | 2 615 000 |
24-03-18 | 6,145 | +2.74% | 2,872,100 |
24-03-15 | 5,981 | -2.06% | 3,292,000 |
24-03-14 | 6,107 | -1.80% | 2,560,300 |
24-03-13 | 6,219 | -3.18% | 2,176,000 |
Delayed Quote Japan Exchange, March 19, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.44% | 67.78B | |
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B |